Safety and Efficacy of 7 Days on/7 Days off Versus 14 Days on/7 Days off Schedules of Capecitabine in Patients with Metastatic Colorectal Cancer: A Retrospective Review-Reference-Cited by-同舟云学术

Safety and Efficacy of 7 Days on/7 Days off Versus 14 Days on/7 Days off Schedules of Capecitabine in Patients with Metastatic Colorectal Cancer: A Retrospective Review

Published:2021-06 Issue:2 Volume:20 Page:153-160
ISSN:1533-0028
Container-title:Clinical Colorectal Cancer
language:en
Short-container-title:Clinical Colorectal Cancer

Author:

Bryson Evan,Sakach Elizabeth,Patel Urvi,Watson Marley,Hall Kevin,Draper Amber,Davis Christine,Goyal Subir,Alese Olatunji^ORCID,Akce Mehmet,Shaib Walid,El-Rayes Bassel,Szabo Stephen,Wu Christina

Publisher

Elsevier BV

Subject

Gastroenterology,Oncology

Reference18 articles.

1. Cancer statistics, 2020;Siegel;CA Cancer J Clin,2020

2. Present and future of metastatic colorectal cancer treatment: a review of new candidate targets;Martini;World J Gastroenterol,2017

3. National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology: Colon Cancer. Version 1.2020, December 19,2019

4. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology: Rectal Cancer. Version 1.2020, December 19,2019

5. Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group;Simkens;Lancet,2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advanced prodrug strategies in nucleoside analogues targeting the treatment of gastrointestinal malignancies;Frontiers in Cell and Developmental Biology;2023-04-18

2. Capecitabine Treatment: A Safe and Effective Therapy in the Field of Oncology;Clinical Colorectal Cancer;2021-09

3. Lessons Learned in Managing Patients with Colorectal Cancer During the COVID-19 Pandemic;Current Treatment Options in Oncology;2021-08-23